NO2580226T3 - - Google Patents
Info
- Publication number
- NO2580226T3 NO2580226T3 NO11725217A NO11725217A NO2580226T3 NO 2580226 T3 NO2580226 T3 NO 2580226T3 NO 11725217 A NO11725217 A NO 11725217A NO 11725217 A NO11725217 A NO 11725217A NO 2580226 T3 NO2580226 T3 NO 2580226T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- C07H13/06—Fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10165707A EP2397484A1 (fr) | 2010-06-11 | 2010-06-11 | Dérivés de triholoside et leur utilisation en tant qu'adjuvants |
EP11725217.1A EP2580226B1 (fr) | 2010-06-11 | 2011-06-03 | Dérivés de triholoside et leur utilisation en tant qu'adjuvants |
PCT/NL2011/050393 WO2011155822A1 (fr) | 2010-06-11 | 2011-06-03 | Dérivés de trisaccharide et leur utilisation comme adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2580226T3 true NO2580226T3 (fr) | 2018-04-28 |
Family
ID=43734127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO11725217A NO2580226T3 (fr) | 2010-06-11 | 2011-06-03 |
Country Status (24)
Country | Link |
---|---|
US (2) | US9327020B2 (fr) |
EP (3) | EP2397484A1 (fr) |
JP (2) | JP6004586B2 (fr) |
KR (1) | KR101929973B1 (fr) |
CN (1) | CN103154013B (fr) |
AU (1) | AU2011262606B2 (fr) |
BR (1) | BR112012031440A2 (fr) |
CA (1) | CA2802023C (fr) |
CY (1) | CY1119704T1 (fr) |
DK (1) | DK2580226T3 (fr) |
ES (1) | ES2654156T3 (fr) |
HR (1) | HRP20171947T1 (fr) |
HU (1) | HUE035187T2 (fr) |
IL (1) | IL223570A (fr) |
LT (1) | LT2580226T (fr) |
MX (1) | MX342946B (fr) |
NO (1) | NO2580226T3 (fr) |
PL (1) | PL2580226T3 (fr) |
PT (1) | PT2580226T (fr) |
RS (1) | RS56690B1 (fr) |
RU (1) | RU2595717C2 (fr) |
SI (1) | SI2580226T1 (fr) |
WO (1) | WO2011155822A1 (fr) |
ZA (1) | ZA201209395B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2397484A1 (fr) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Dérivés de triholoside et leur utilisation en tant qu'adjuvants |
AU2015294769B2 (en) * | 2014-07-24 | 2020-07-16 | Litevax B.V. | Adjuvants |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4232150A (en) * | 1979-07-09 | 1980-11-04 | American Cyanamid Company | Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses |
GB8703128D0 (en) * | 1987-02-11 | 1987-03-18 | Donmarn Ltd | Anti-scaling compounds |
US5543505A (en) * | 1993-03-15 | 1996-08-06 | Sloan-Kettering Institute For Cancer Research | Synthetic compounds which bind to H. pylori, and uses thereof |
US6303120B1 (en) * | 1994-03-15 | 2001-10-16 | Memorial Sloan-Kettering Institute For Cancer Research | Synthesis of glycoconjugates of the lewis y epitope and uses thereof |
US5708163A (en) * | 1994-03-15 | 1998-01-13 | Sloan-Kettering Institute Of Cancer Research | Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof |
MX9701394A (es) * | 1994-08-04 | 1998-03-31 | Quadrant Holdings Cambridge | Sistemas de administracion de solidos para la liberacion controlada de moleculas incorporadas en losmismos y metodos para hacer los mismos. |
BE1008978A5 (fr) | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
US6517860B1 (en) * | 1996-12-31 | 2003-02-11 | Quadrant Holdings Cambridge, Ltd. | Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery |
US6352722B1 (en) * | 1997-12-23 | 2002-03-05 | Quadrant Holdings Cambridge Limited | Derivatized carbohydrates, compositions comprised thereof and methods of use thereof |
JP3041799B1 (ja) * | 1998-09-29 | 2000-05-15 | 株式会社微生物化学研究所 | 新規なアジュバント及びそれを用いたワクチン |
EP1104767A1 (fr) * | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Dérivés de mono- et disaccharides contenant esters d'acides gras et esters de sulfate |
GB0124710D0 (en) * | 2001-10-15 | 2001-12-05 | Quadrant Healthcare Uk Ltd | Therapeutic composition |
DE602005010101D1 (de) * | 2005-12-01 | 2008-11-13 | Wella Ag | Verwendung von Di- oder Oligosaccharidepolyestern in Haarstylingprodukten |
US9045516B2 (en) * | 2007-04-16 | 2015-06-02 | Suri Saranathan Iyer | Synthetic ligands for the differentiation of closely related toxins and pathogens |
US9242010B2 (en) * | 2008-05-16 | 2016-01-26 | Research Foundation Of The City University Of New York | Living copolymer-protein/peptide hybrids for biomedical applications |
ES2610240T3 (es) * | 2009-02-02 | 2017-04-26 | Otsuka Chemical Co., Ltd. | Derivado de ácido hialurónico polisulfatado de bajo peso molecular y medicamento que lo contiene |
EP2397484A1 (fr) * | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Dérivés de triholoside et leur utilisation en tant qu'adjuvants |
-
2010
- 2010-06-11 EP EP10165707A patent/EP2397484A1/fr not_active Withdrawn
-
2011
- 2011-06-03 ES ES11725217.1T patent/ES2654156T3/es active Active
- 2011-06-03 MX MX2012014422A patent/MX342946B/es active IP Right Grant
- 2011-06-03 LT LTEP11725217.1T patent/LT2580226T/lt unknown
- 2011-06-03 EP EP17204140.2A patent/EP3312188A1/fr not_active Withdrawn
- 2011-06-03 NO NO11725217A patent/NO2580226T3/no unknown
- 2011-06-03 JP JP2013514126A patent/JP6004586B2/ja not_active Expired - Fee Related
- 2011-06-03 EP EP11725217.1A patent/EP2580226B1/fr active Active
- 2011-06-03 AU AU2011262606A patent/AU2011262606B2/en not_active Ceased
- 2011-06-03 KR KR1020137000623A patent/KR101929973B1/ko active IP Right Grant
- 2011-06-03 PL PL11725217T patent/PL2580226T3/pl unknown
- 2011-06-03 WO PCT/NL2011/050393 patent/WO2011155822A1/fr active Application Filing
- 2011-06-03 RS RS20171307A patent/RS56690B1/sr unknown
- 2011-06-03 BR BR112012031440A patent/BR112012031440A2/pt not_active Application Discontinuation
- 2011-06-03 CN CN201180034937.5A patent/CN103154013B/zh not_active Expired - Fee Related
- 2011-06-03 CA CA2802023A patent/CA2802023C/fr not_active Expired - Fee Related
- 2011-06-03 DK DK11725217.1T patent/DK2580226T3/en active
- 2011-06-03 PT PT117252171T patent/PT2580226T/pt unknown
- 2011-06-03 HU HUE11725217A patent/HUE035187T2/hu unknown
- 2011-06-03 SI SI201131368T patent/SI2580226T1/en unknown
- 2011-06-03 US US13/703,329 patent/US9327020B2/en not_active Expired - Fee Related
- 2011-06-03 RU RU2013100945/04A patent/RU2595717C2/ru active
-
2012
- 2012-12-11 ZA ZA2012/09395A patent/ZA201209395B/en unknown
- 2012-12-11 IL IL223570A patent/IL223570A/en active IP Right Grant
-
2016
- 2016-04-05 US US15/090,853 patent/US20170057987A1/en not_active Abandoned
- 2016-06-15 JP JP2016119032A patent/JP2016216471A/ja active Pending
-
2017
- 2017-12-14 HR HRP20171947TT patent/HRP20171947T1/hr unknown
- 2017-12-21 CY CY20171101340T patent/CY1119704T1/el unknown